BioNexus Gene Lab (BGLC) Asset Utilization Ratio (2019 - 2026)

BioNexus Gene Lab (BGLC) has 8 years of Asset Utilization Ratio data on file, last reported at 0.58 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio fell 37.61% year-over-year to 0.58; the trailing twelve-month figure through Mar 2026 stood at 0.58 (down 37.61% YoY), and the FY2025 full-year result was 0.75, down 13.42% from the prior year.
• Asset Utilization Ratio slipped to 0.58 in Q1 2026, from 0.88 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 1.41 in Q2 2022 to a low of 0.58 in Q1 2026.
• A 5-year average of 1.05 and a median of 1.01 in 2025 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio jumped 57.95% in 2022 and slumped 37.61% in 2026, its largest moves.
• Tracing BGLC's Asset Utilization Ratio over 5 years: stood at 1.32 in 2022, then slumped by 35.33% to 0.85 in 2023, then climbed by 3.86% to 0.89 in 2024, then dropped by 0.86% to 0.88 in 2025, then slumped by 34.02% to 0.58 in 2026.
• Business Quant data shows BGLC's Asset Utilization Ratio at 0.58 in Q1 2026, 0.88 in Q4 2025, and 1.11 in Q3 2025.